• For US Healthcare Professionals
  • For Patients and Caregivers
A A A

Resource Center >

My Patient Solutions®
  • Patients and Caregivers
  • Learn About Our Services
    • LUCENTIS Coverage
    • Reimbursement
    • LUCENTIS Distribution
    • My Patient Solutions
  • Find Patient Assistance
    • Referrals to Genentech Co-pay Programs
    • Referrals to Independent Co-pay Assistance Foundations
    • Referrals to the Genentech Patient Foundation
  • Forms & Documents

Resource Center >

My Patient Solutions®
  • ACTEMRA® (tocilizumab)‎
  • ALECENSA® (alectinib)
  • AVASTIN® (bevacizumab)
  • COTELLIC® (cobimetinib)
  • ENSPRYNG™ (satralizumab-mwge)
  • ERIVEDGE® (vismodegib)
  • ESBRIET® (pirfenidone)
  • Evrysdi™ (risdiplam)
  • GAZYVA® (obinutuzumab)
  • HEMLIBRA® (emicizumab-kxwh)
  • HERCEPTIN® (trastuzumab)
  • Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk)
  • KADCYLA® (ado-trastuzumab emtansine)
  • LUCENTIS® (ranibizumab injection)
  • OCREVUS® (ocrelizumab)
  • PERJETA® (pertuzumab)
  • PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
  • POLIVY® (polatuzumab vedotin-piiq)
  • PULMOZYME® (dornase alfa) Inhalation Solution
  • RITUXAN® (rituximab)
  • RITUXAN HYCELA® (rituximab/hyaluronidase human)
  • ROZLYTREK™ (entrectinib)
  • TECENTRIQ® (atezolizumab)
  • VENCLEXTA® (venetoclax tablets)
  • XELODA® (capecitabine)
  • XOLAIR® (omalizumab) for subcutaneous use
  • ZELBORAF® (vemurafenib)
  • ONCOLOGY
  • RHEUMATOLOGY

Please select a treatment to continue

  • ACTEMRA® (tocilizumab)‎
  • ALECENSA® (alectinib)
  • AVASTIN® (bevacizumab)
  • COTELLIC® (cobimetinib)
  • ENSPRYNG™ (satralizumab-mwge)
  • ERIVEDGE® (vismodegib)
  • ESBRIET® (pirfenidone)
  • Evrysdi™ (risdiplam)
  • GAZYVA® (obinutuzumab)
  • HEMLIBRA® (emicizumab-kxwh)
  • HERCEPTIN® (trastuzumab)
  • Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk)
  • KADCYLA® (ado-trastuzumab emtansine)
  • LUCENTIS® (ranibizumab injection)
  • OCREVUS® (ocrelizumab)
  • PERJETA® (pertuzumab)
  • PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
  • POLIVY® (polatuzumab vedotin-piiq)
  • PULMOZYME® (dornase alfa) Inhalation Solution
  • RITUXAN® (rituximab)
  • RITUXAN HYCELA® (rituximab/hyaluronidase human)
  • ROZLYTREK™ (entrectinib)
  • TECENTRIQ® (atezolizumab)
  • VENCLEXTA® (venetoclax tablets)
  • XELODA® (capecitabine)
  • XOLAIR® (omalizumab) for subcutaneous use
  • ZELBORAF® (vemurafenib)
  • Or Select

  • ONCOLOGY
  • RHEUMATOLOGY

Please select a treatment to continue

Select a disease state for Rituxan® (rituximab)

  • Rituxan® (rituximab) for Rheumatoid Arthritis (RA)
  • Rituxan® (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
  • RITUXAN® (rituximab) for Oncology
  • Rituxan® (rituximab) for Pemphigus Vulgaris (PV)

LUCENTIS Access Solutions

Committed to helping patients access the Genentech medicine they have been prescribed

Enroll Now

Submit our forms online or by text for faster and easier enrollment

Patient
Assistance Tool

Find the right assistance option for your patients 

Coverage

Help understanding benefits and coverage, such as benefits investigations and prior authorization resources

 

Learn More >

Reimbursement

Sample coding information and resources for denials and appeals

 

Learn More >

Product Distribution

A list of authorized distributors and specialty pharmacies as well as information on our Spoilage Replacement Program 

 

Learn More >

Learn About Treatment With LUCENTIS >

Download the forms you need to get started

View LUCENTIS Forms and Documents >

Latest Updates

New enrollment forms

Learn More >

 

Genentech Patient Foundation

Learn More >

2021
  • Contact Us
  • Site Map
  • Privacy Policy
  • Terms & Conditions
  • Cookie Preferences

©[YEAR] Genentech USA, Inc.  All rights reserved.  This site is intended for US residents only.
The Access Solutions logo is a registered trademark of Genentech, Inc.

Link to Third Party Site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel OK

Link to Healthcare Professionals Site

The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.

Cancel OK

Cancel

Your email has been sent!

Thanks for sharing this page.